Doctors Called It Anxiety. It Took a Medical Student's Hunch to Realize She'd Discovered a New Disease.

The Girl Who Was Allergic to Everything

When Maya Ostrander was thirteen, she broke out in hives after swimming in Lake Michigan. Her doctor told her family it was probably a contact reaction — lake water, algae, something environmental. They gave her an antihistamine and sent her home.

When she was fifteen, she had a severe allergic episode after a car ride. Not after eating anything. Not after touching anything unusual. Just from sitting in a moving vehicle for forty minutes.

By the time she was seventeen, Maya had been seen by four allergists, two immunologists, a dermatologist, and a pediatric rheumatologist. She had tested negative for every standard allergen panel available. Her reactions — hives, swelling, difficulty breathing, plummeting blood pressure — were real and measurable. But nobody could figure out what was causing them.

The working theory, by the time she aged into adult care, was that she had a psychosomatic condition. Stress-induced. Possibly anxiety-related. She was referred to a therapist.

Maya kept having reactions.

A Chart That Didn't Add Up

In 2014, Maya was being seen at a university hospital in Chicago as part of an ongoing effort to get answers. Her case had become something of a teaching file — complex, unresolved, and genuinely puzzling. Second-year medical students occasionally reviewed it as an exercise in diagnostic reasoning.

One of those students was a 24-year-old named David Cho.

Cho wasn't looking for anything groundbreaking. He was doing a chart review assignment. But as he read through Maya's six years of documented reactions, something caught his attention that the specialists had apparently treated as coincidence: the reactions didn't seem random at all. They followed a pattern. Specifically, they appeared to be triggered by physical stimuli — pressure, temperature change, vibration, and light — rather than by chemical or biological allergens.

Cho took his observation to his supervising resident, who was skeptical but willing to pass it up the chain. The resident mentioned it to an attending immunologist. The immunologist, to her credit, took it seriously.

A Condition Nobody Had Named

What Cho had stumbled onto was a cluster of symptoms consistent with what researchers now recognize as a rare and poorly understood subset of mast cell activation disorders — specifically, a pattern in which mast cells (the immune cells responsible for allergic responses) are triggered not by allergens but by physical forces acting on the body.

Individual physical triggers for allergic responses weren't entirely new to medicine. Doctors had documented things like cold urticaria (hives from cold temperatures) and dermatographism (hives from skin pressure) for years. But Maya's case presented something different: a patient whose mast cells appeared to be hypersensitive to multiple distinct physical stimuli simultaneously, in a way that produced systemic reactions rather than localized ones.

Over the following two years, the Chicago team — led by the attending immunologist, Dr. Patricia Rhee — worked with Maya to document and map her triggers in a controlled clinical setting. They also began searching the literature for similar cases. They found eleven, scattered across medical journals from four different countries, none of which had been connected to each other.

In 2016, Rhee and her colleagues published a paper in a peer-reviewed immunology journal proposing a formal classification for the condition. They called it multistimulus physical urticaria syndrome, or MPUS. The paper described Maya's case in detail (with her consent) alongside the eleven historical cases, and outlined a diagnostic framework for identifying similar patients.

What It Meant for Everyone Who Came After

The 2016 paper didn't make headlines. Medical discoveries rarely do, unless they're dramatic enough for a press release. But within immunology circles, it circulated widely. Specialists began looking at their own mystery cases through the new lens.

Within three years of publication, researchers had identified over 400 patients in the United States alone whose histories were consistent with MPUS. Many had spent years being told their symptoms were psychological. Some had been on long-term anxiety medication. A few had stopped seeking care entirely, convinced that no one would ever believe them.

For those patients, the diagnosis was the first concrete acknowledgment that what they were experiencing was real, measurable, and — importantly — treatable. While there's no cure for MPUS, targeted mast cell stabilizing medications have been shown to significantly reduce the frequency and severity of reactions in most patients.

Maya Ostrander, now in her late twenties, has spoken publicly about her experience. She's described the years of being dismissed as the hardest part — harder, even, than the reactions themselves. Being told your body is lying to you, she's said, does something to a person.

The Accidental Discoverer

David Cho finished medical school and went on to specialize in internal medicine. He's been characteristically modest about his role in the discovery, pointing out that he simply read a chart carefully and asked a question. The real work, he's said, was done by Dr. Rhee and her team.

That's probably true. But it's also true that the chart had been read before. Multiple times, by multiple specialists. None of them had asked the same question.

Sometimes the most important diagnostic tool in medicine isn't a blood panel or an imaging machine. Sometimes it's a second-year student with fresh eyes and the nerve to say: wait, does anyone else see a pattern here?

For Maya, and for the thousands of patients now living with an actual diagnosis instead of a shrug, the answer to that question changed everything.